ArticleCureus2026
Progressive Pulmonary Cystic Disease in Autoimmune Hepatitis and Rheumatoid Arthritis: A Rare Association.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary cystic lung disease is an uncommon manifestation of systemic autoimmune disorders. Rheumatoid arthritis (RA) is most often associated with interstitial lung disease, whereas pulmonary involvement in autoimmune hepatitis (AIH) is rare. We describe an 82-year-old woman with longstanding RA and AIH who demonstrated progressive bilateral pulmonary cystic disease over a 15-year period, complicated by acute hypoxemic respiratory failure and the new identification of a pulmonary arteriovenous malformation. Interval imaging revealed progression of thin-walled pulmonary cysts and fibrotic changes compared with prior studies. This case highlights a rare overlap of autoimmune conditions associated with cystic lung disease and emphasizes the importance of longitudinal imaging, medication review, and multidisciplinary management in patients with complex autoimmune disease presenting with dyspnea.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.